Literature DB >> 14871061

Primary prevention of essential hypertension.

Marie A Krousel-Wood1, Paul Muntner, Jiang He, Paul K Whelton.   

Abstract

The best approach to the primary prevention of hypertension is a combination of lifestyle changes: weight loss in overweight persons; increased physical activity; moderation of alcohol intake; and consumption of a diet that is higher in fruits, vegetables, and low-fat dairy products and lower in sodium content than the average American diet (Table 3). Recent randomized controlled trials have demonstrated that these lifestyle changes can be sustained over long periods of time (more than 3 years) and can have blood pressure-lowering effects as large as those seen in drug studies. Hypertension is an important preventable risk factor for cardiovascular disease, the leading cause of mortality in the United States. To achieve the Healthy People 2010 goal of reducing the proportion of adults with hypertension from 28% to 16%, concerted efforts must be directed toward primary prevention strategies. Lifestyle modifications including weight loss, increased physical activity, and dietary changes in individuals have been shown to reduce the incidence of hypertension and should be recommended for all persons and especially those with prehypertension. In addition, timely adoption of prevention strategies to reduce the incidence of hypertension and its subsequent complications in the general population may interrupt the costly cycle of hypertension and prevent the reductions in quality of life associated with this chronic disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14871061     DOI: 10.1016/s0025-7125(03)00126-3

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  20 in total

1.  Child and adolescent health in Northern Ontario: a quantitative profile for public health planning.

Authors:  Mary S Ward; Vic S Sahai; Kate C Tilleczek; Jennifer L Fearn; Robert C Barnett; Tim Zmijowskyj
Journal:  Can J Public Health       Date:  2005 Jul-Aug

Review 2.  Liver cirrhosis and arterial hypertension.

Authors:  Jens H Henriksen; Soren Moller
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

3.  Different antioxidants status, total antioxidant power and free radicals in essential hypertension.

Authors:  Manoj K Kashyap; Vibha Yadav; Badan S Sherawat; Sanjay Jain; Savita Kumari; Madhu Khullar; Prakash C Sharma; Ravinder Nath
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

4.  Cost of poor adherence to anti-hypertensive therapy in five European countries.

Authors:  F S Mennini; A Marcellusi; J M Graf von der Schulenburg; A Gray; P Levy; P Sciattella; M Soro; G Staffiero; J Zeidler; A Maggioni; R E Schmieder
Journal:  Eur J Health Econ       Date:  2014-01-05

5.  Respiratory sinus arrhythmia and diseases of aging: obesity, diabetes mellitus, and hypertension.

Authors:  Christopher M Masi; Louise C Hawkley; Edith M Rickett; John T Cacioppo
Journal:  Biol Psychol       Date:  2006-10-10       Impact factor: 3.251

Review 6.  Hypertension and liver disease.

Authors:  Jens H Henriksen; Søren Møller
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

7.  Health behaviors and racial disparity in blood pressure control in the national health and nutrition examination survey.

Authors:  Nicole Redmond; Heather J Baer; Leroi S Hicks
Journal:  Hypertension       Date:  2011-02-07       Impact factor: 10.190

8.  Dietary approaches to prevent hypertension.

Authors:  Lydia A Bazzano; Torrance Green; Teresa N Harrison; Kristi Reynolds
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

Review 9.  Recommendations for global hypertension monitoring and prevention.

Authors:  Drew E Lee; Richard S Cooper
Journal:  Curr Hypertens Rep       Date:  2009-12       Impact factor: 5.369

10.  Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics.

Authors:  J H Henriksen; S Fuglsang; F Bendtsen; S Møller
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.